pharmaceutical economics
The End of an Era: Why Phasing Out Animal Testing is Biotech’s Next Multi-Trillion Dollar Investment Opportunity
A major regulatory shift is ending the era of mandated animal testing, creating a massive financial and competitive advantage for biotech firms.